Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Accelrys Releases Materials Studio 5.0: Transforming Modeling & Simulation for Chemical and Materials Research

Wed. October 14, 2009; Posted: 04:00 AM
Stocks RSS
BARCELONA, SPAIN, Oct 14, 2009 (MARKETWIRE via COMTEX) -- ACCL | Quote | Chart | News | PowerRating -- Accelrys European User Group Meeting -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific business intelligence software and services, today announced the release of Materials Studio 5.0. This state-of-the-art modeling and simulation platform builds on Accelrys' foundation for transforming the efficiency and effectiveness of chemical and materials research. The new release includes a host of integrated product enhancements -- ranging from advanced instrument simulation and visualization tools, to new and improved parallel codes -- delivering the performance and usability that today's chemists, physicists and materials scientists need to increase research productivity and speed time-to-innovation.

"This product release furthers Accelrys' commitment to delivering tools that not only streamline the scientific cycle, but also increase the relevance of scientific findings to business functions such as product engineering and design," said Dr. Frank Brown, senior vice president and chief science officer at Accelrys. "With sophisticated tools for materials science research like Materials Studio 5.0, scientists can make breakthrough discoveries faster."

Providing a single, integrated platform for advanced modeling and simulation, Materials Studio enables scientists to more easily and efficiently perform highly complex research. Version 5.0 incorporates highly efficient parallel codes and supports a wider range of polymer and instrument simulations, delivering the industry's fastest time-to-solution for sophisticated modeling tasks. The solution has already been proven in numerous research-driven industries, including specialty chemicals, pharmaceuticals, consumer packaged goods, heavy manufacturing, and electronics.

About Materials Studio 5.0

Accelrys Materials Studio transforms the way that researchers in chemistry, physics and materials science work to deliver breakthrough results. Version 5.0 enables scientists to explore a wider design space and make better informed decisions in research on catalysis, polymers, specialty chemicals and advanced materials. This scientifically sophisticated simulation environment dramatically reduces time to innovation by increasing research productivity while simultaneously delivering more relevant results to engineering, product design, and marketing teams. Specific enhancements include:

--  Extensions to the easy-to-use graphical user environment which
    simplifies highly complex modeling and simulation activities.  For example,
    Materials Studio 5.0 now provides graphical representations of reciprocal
    space (Brillouin Zones), crucial for understanding the electron behavior of
    solid-state materials.

--  New and improved parallel codes at every simulation scale (including
    quantum, classical, atomistic, mesocale), for shorter turn-around times on
    even the most challenging modeling and simulation tasks.

--  An integrated and extended set of tools for polymer and soft matter
    research, including  new versions of Amorphous Cell, Forcite Plus and
    Mesocite that provide more and faster ways to model complex materials than
    ever before, all with a minimum of human interaction and computing
    resources.

--  A wider range of analytical instrument simulations, including Raman
    spectra calculations in CASTEP.


Materials Studio 5.0 will be generally available in the fourth calendar quarter of 2009.

For a full list of Materials Studio 5.0 enhancements and to register for the upcoming web seminar series, please visit http://accelrys.com/events/webinars/materials-studio-50/index.html.

Customers Benefit from Materials Studio 5.0

Dozens of users across all key industries have already seen solid results using early, Beta releases of Materials Studio 5.0.

--  The Procter and Gamble Company (http://www.pg.com/)
    "I'm quite impressed with the speedup I'm seeing with Forcite Plus in
    Materials Studio 5.0. With the parallel version of Forcite Plus working
    with COMPASS, and scaling so well up to 128 CPUs, we'll be able to use
    it in a variety of projects."
    -- Kelly Anderson, Senior Scientist, Modeling & Simulation, Corporate
       R&D, P&G USA
--  PQ Corporation (http://www.pqcorp.com/)
    "The new Raman functionality in CASTEP enabled me to accurately
    reproduce the experimental Raman spectra of large real silicate
    crystals.  One can expect that this functionality will be highly
    beneficial for characterizing, understanding, and predicting the
    molecular constitution of a variety of complex materials."
    -- Istvan Halasz, Principal Chemist, PQ Corporation, USA
--  Taiyo Yuden (http://www.t-yuden.com/)
    "The new Raman spectra prediction in CASTEP is very easy to use. We
    confirmed it gives us valuable information which compares well with
    experimental results for a wide variety of insulators."
    -- Yoshiki Iwazaki, Researcher, Taiyo Yuden Co., Ltd., Japan
--  Army Research Laboratory
    "We expect the new Amorphous Cell functionality to allow us to better
    study adhesion of polymers to semiconductor surfaces and nanoparticles.
    The study of multifunctional nanocomposites is important for a variety
    of Army applications."
    -- Jan Andzelm, Ph.D., Computational Chemist, Army Research Laboratory,
       USA

About Accelrys, Inc.

Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. Accelrys has a vast portfolio of computer-aided design modeling and simulation offerings which assist customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Its scientific business intelligence platform underlies the company's computer-aided design modeling and simulation offerings. The Accelrys platform can be used with both Accelrys and competitive products, as well as with customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit http://accelrys.com/

Forward-Looking Statements

This press release contains forward-looking statements. Such statements, including statements relating to the Company's Materials Studio 5.0 software products, their features, and their impact upon our customers' organizations, are subject to risks and uncertainties including, but not limited to, the risk that our products will not be successfully completed, achieve market acceptance, have the anticipated impact upon our customers' organizations, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

SOURCE: Accelrys

 
For full details for ACCL click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [ACCL]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.